# A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

> **NCT06885424** · — · ENROLLING_BY_INVITATION · sponsor: **A2 Biotherapeutics Inc.** · enrollment: 400 (estimated)

## Conditions studied

- Solid Tumor Cancer
- Solid Tumor, Unspecified, Adult
- Colorectal Carcinoma
- Colorectal Carcinoma (CRC)
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer ( SCLC )
- Pancreatic Cancer
- NSCLC
- Mesothelioma
- Ovarian Cancer
- Ovarian Carcinoma
- Head and Neck (HNSCC)
- Head and Neck Cancer
- Renal Cell Carcinoma (Kidney Cancer)
- Triple Negative Breast Cancer (TNBC)

## Interventions

- **OTHER:** No additional intervention administered in this long term follow-up study

## Key facts

- **NCT ID:** NCT06885424
- **Lead sponsor:** A2 Biotherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-31
- **Primary completion:** 2030-03-31
- **Final completion:** 2040-03-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06885424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06885424, "A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06885424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*